- Home
- » Tags
- » MRI contrast agent
Top View
- Signature Redacted Redacted
- First Clinical Experience with the Magnetic Resonance Imaging Contrast Agent and Superoxide Dismutase Mimetic Mangafodipir As An
- Metal-Based Complexes As Pharmaceuticals for Molecular Imaging of the Liver
- AMM Template
- Acidocest-UTE MRI for the Assessment of Extracellular Ph of Joint Tissues at 3 T
- Dotarem 279.32 Mg/Ml Solution for Injection in Pre-Filled Syringes
- 1196591 IND.Indd
- Gadolinium-Based Layered Double Hydroxide and Graphene Oxide
- Preparation and Initial Characterization of Biodegradable
- Original Article Gadopentetic Acid-Doped, Multifunctional
- Magneto-Liposomes As MRI Contrast Agents: a Systematic Study of Different Liposomal Formulations
- 201911 Reveal
- Quantitative Evaluation of Contrast Agent Dynamics in Liver MRI
- Enhancing T1 Magnetic Resonance Imaging Contrast with Internalized Gadolinium(III) in a Multilayer Nanoparticle
- Questions & Answers Re NSF and Gadolinium, 26 June 2007
- The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances
- Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
- Ml Solution for Injection Clariscan 0.5 Mmol/ Ml Solution for Injection in Pre-Filled Syringe
- Superparamagnetic Iron Oxide Nanoparticles in Biomedicine
- AMM Template
- Large T1 Contrast Enhancement Using Superparamagnetic Nanoparticles in Ultra-Low Feld MRI Received: 3 April 2018 Xiaolu Yin1,2, Stephen E
- Repurposing Clinical Agents for Chemical Exchange Saturation Transfer Magnetic Resonance Imaging: Current Status and Future Perspectives
- Magnetic Resonance Imaging Contrast Agents: a Review of Literature Zahra Sahraei1, Mehran Mirabzadeh2, Daniel Fadaei Fouladi 3, Neda Eslami4, Azadeh Eshraghi5*
- Study on Establishing Reference Safe Concentrations of MRI Contrast Agents for Optimized Images: Paramagnetic Gd-DTPA-BMEA and Superparamagnetic Ferucarbotran
- Recent Advances on Ultrasound Contrast Agents for Blood-Brain Barrier Opening with Focused Ultrasound
- Prussian Blue Nanoparticles and Its Analogues As New-Generation T1-Weighted MRI Contrast Agents
- Behavior of Gadolinium-Based Diagnostics in Water Treatment
- 201277Orig1s000
- The Magnetic Resonance Imaging Contrast Agent Mangafodipir Exerts Antitumor Activity Via a Previously Described Superoxide Dismutase Mimetic Activity
- Dynamic Contrast Enhanced MRI with Clinical Hepatospecific MRI Contrast Agents in Pigs: Initial Experience
- Bimodal Magnetic Resonance Imaging-Computed Tomography Nanoprobes: a Review
- Gadolinium As an Emerging Microcontaminant in Water Resources: Threats and Opportunities
- United States Patent (19) 11 Patent Number: 5,064,636 Li Et Al
- Application for Inclusion of Gadoterate Meglumine Pdf, 853Kb
- MRI Contrast Agents: Classification and Application (Review)
- Manganese Based MR Contrast Agents: Formulation and Clinical Applications
- Iron Oxide Nanoparticles: an Alternative for Positive Contrast in Magnetic Resonance Imaging
- Iron Oxide Nanoparticles As a Contrast Agent for Thermoacoustic Tomography
- PRIMOVIST 0.25 Mmol/Ml Solution for Injection
- Side Effects of Gadolinium MRI Contrast Agents Ahmed Uosef, Martha Villagran, Jacek Z
- 1199505 LBN.Indd
- MRI Contrast Enhancement and Cell Labeling Using Gd2o3 Nanoparticles
- Synthesis and Development of Diagnostic Tools for Medical Imaging
- Nanotechnology and Diagnostic Imaging: New Advances in Contrast Agent Technology Joshua E
- May Mangafodipir Or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?